Filing Details
- Accession Number:
- 0001179110-20-000624
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-16 19:38:30
- Reporting Period:
- 2020-01-15
- Accepted Time:
- 2020-01-16 19:38:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1350653 | Alphatec Holdings Inc. | ATEC | Surgical & Medical Instruments & Apparatus (3841) | 202463898 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1509282 | E Craig Hunsaker | C/O Alphatec Spine, Inc. 5818 El Camino Real Carlsbad CA 92008 | Evp, People/Culture & Gc | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-01-02 | 500 | $0.00 | 794,948 | No | 5 | G | Direct | |
Common Stock | Disposition | 2020-01-15 | 32,000 | $7.75 | 762,948 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2020-01-15 | 100,000 | $2.00 | 862,948 | No | 4 | M | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | G | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants (right to buy) | Disposition | 2020-01-15 | 100,000 | $0.00 | 100,000 | $2.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
100,000 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2019.
- Each Warrant is exercisable for 1 share of the issuer's common stock for a period of five years following June 15, 2017 (the date that shareholder approval was obtained).